entities or whether they represent a spectrum of one disease process. [3] [4] [5] [6] [7] [8] International collaborators have suggested that EM and SJS could be separated as 2 distinct clinical disorders with similar mucosal reactions but different patterns of cutaneous lesions.
According to a consensus definition, SJS was separated from the EM spectrum and added to toxic epidermal necrolysis (TEN). 4 The two spectra are now divided into the following: (1) EM consisting of erythema minor and major and (2) Metronidazole is a nitroimidazole antimicrobial medication used particularly for anaerobic bacteria and protozoa. It is on the World Health Organizations list of essential medicines, a list of the most important medications needed in a basic health system.
Pantoprazole is a proton pump inhibitor drug that inhibits gastric acid secretion. The uses of pantoprazole includes gastroesophageal reflux disease, duodenal or gastric ulcers, treatment of pathological hypersecretory conditions, Helicobacter pylori infections, etc.
Cases of ciprofloxacin-induced EM have been reported.
12,13
EM associated with the use of metronidazole and pantoprazole has been relatively very rare.
CASE REPORT
A 39-year-old male patient presented to the dermatology outpatient department, Adichunchanagiri Hospital and Research Centre, B.G. Nagar, with complaints of rashes all over the body since 1-day. The patient gives a history of road traffic accident following which he injured his right leg. The patient was prescribed tablet lakcip (ciprofloxacin) 500 mg BD, tablet flagyl (metronidazole) 400 mg BD, and tablet PAN (pantoprazole) 40 mg BD before food for the non-healing wound in his right leg. The consumption of these medications resulted in the appearance of the rashes for which he sought medical help. The rashes were characterized by central hyperpigmented area surrounded by dusky red papillae. The rashes were associated with itching. On examination, random blood sugar was 304 mg/dl. General physical examination and systemic examinations revealed no abnormality. The patient was treated with calosoft (calamine) lotion, tablet atarax (hydroxyzine) 25 mg HS, injection dexona (dexamethasone) 2 ml i.m stat, injection avil (chlorpheniramine) 2 ml i.m stat. Rashes reduced. Rechallenge was not done (Figure 1a and b) .
DISCUSSION
EM is a type of hypersensitivity reaction, which occurs in response to medicines, infections or illnesses. EM minor presents with localized eruptions of the skin with minimal or no mucosal involvement. The papules evolve into pathognomonic target lesions or iris lesions that appear within a 72 hrs period and begin on the extremities. Lesions remain in a fixed location for at least 7 days and then begin to heal. Lesions may also appear as arcuate lesions. Precipitating factors include herpes simplex virus, EpsteinBarr virus, and histoplasmosis. Because this condition may be related to a persistent antigenic stimulus, recurrence is the rule rather than the exception, with most affected individuals experiencing 1-2 recurrences per year. The pathophysiology of EM is still not completely understood, but it is probably immunologically-mediated and appears to involve a hypersensitivity reaction that can be triggered by a variety of stimuli, particularly bacterial, viral, or chemical products. 2 Cell-mediated immunity appears to be responsible for the destruction of epithelial cells. Early in the disease process, the epidermis becomes infiltrated with CD8 T-lymphocytes and macrophages, whereas the dermis displays a slight influx of CD4 lymphocytes. These immunologically active cells are not present in sufficient numbers to be directly responsible for the epithelial cell death. Instead, they release diffusible cytokines, which mediate the inflammatory reaction and resultant apoptosis of epithelial cells. In some patients, circulating T-cells transiently demonstrate (for <30 days) a T-helper cell type 1 cytokine response (interferon gamma, tumor necrosis factor [TNF] alpha, interleukin-2). Results of immunohistochemical analysis have also shown lesion blister fluid to contain TNF, an important proinflammatory cytokine.
2
Other evidence supports the hypothesis that the disease is the result of cell-mediated immune reactions. Individuals possessing human leukocyte antigen-B12 are 3 times more likely to develop this disorder. The classic timing for a primary cell-mediated immune reaction is 9-14 days after the initiation of the offending drug. In recurrent exposure, the reaction occurs within several hours to 1-2 days, which is consistent with the timing of a secondary cell-mediated immune response. 2 The review of literature has revealed very rare associations of metronidazole and pantoprazole with EM. Hence the reported adverse drug reaction has been attributed to ciprofloxacin.
15,16
In this event, casualty assessment using Naranjo's scale revealed that ciprofloxacin was a probable cause for the adverse drug reaction. 17 
